Lantheus Cash Flow Statement
NASDAQ: LNTHHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Lantheus free cash flow
In fiscal 2025, Lantheus generated $390.1 million of operating cash flow and spent $36.1 million on capital expenditures. That left free cash flow of $354.1 million, a free-cash-flow margin of 23.0% of revenue. Free cash flow was down 28.2% from the prior year's $493.1 million.
Lantheus returned $300.0 million to shareholders through share repurchases, equal to 85% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Lantheus cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 233.56M | 312.44M | 326.66M | 28.07M | -71.28M | -13.47M | 31.67M | 40.52M | 123.39M | 26.76M |
| Net Income growth (YoY) | -25.25% | -4.35% | +1063.86% | — | — | -142.55% | -21.84% | -67.16% | +361.05% | — |
| Depreciation & Amortization | 70.10M | 64.62M | 60.04M | 47.93M | 42.29M | 24.69M | 13.38M | 13.93M | 19.23M | 18.26M |
| Stock-Based Compensation | 85.56M | 76.39M | 50.51M | 29.26M | 15.93M | 14.07M | 12.49M | 8.72M | 5.93M | 2.52M |
| Change in Working Capital | -44.23M | 2.05M | -171.20M | -72.09M | -15.08M | -24.31M | 11.46M | -13.31M | -7.93M | 2.25M |
| Operating Cash Flow | 390.14M | 544.75M | 305.26M | 281.78M | 53.92M | 16.40M | 80.38M | 61.19M | 54.78M | 49.64M |
| Capital Expenditures | -36.09M | -51.63M | -45.34M | -260.00M | 0 | 0 | -22.06M | -20.13M | -17.54M | -7.40M |
| Investing Cash Flow | -627.17M | -226.01M | 5.94M | -276.55M | 3.68M | -4.91M | -22.06M | -19.13M | -16.31M | 3.28M |
| Share Repurchases | -300.02M | -100.00M | 0 | -75.00M | 0 | 0 | — | — | — | — |
| Debt Issued | — | 0 | 0 | 557.75M | 0 | 0 | 199.46M | 0 | 274.31M | 0 |
| Debt Repaid | -1.11M | -318.00K | -717.00K | -175.38M | -43.35M | -15.49M | -275.38M | -2.86M | -286.69M | -78.73M |
| Financing Cash Flow | -316.58M | -118.54M | -13.06M | 311.69M | -39.33M | -21.86M | -78.88M | -4.67M | -13.45M | -30.22M |
| Net Change in Cash | -553.66M | 199.20M | 298.04M | 316.59M | 17.96M | -10.22M | -20.48M | 37.11M | 25.11M | 22.58M |
| Free Cash Flow | 354.05M | 493.13M | 259.92M | 21.78M | 53.92M | 16.40M | 58.32M | 41.06M | 37.23M | 42.24M |
This table shows 10 annual periods of Lantheus's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow LNTH's reporting calendar. What is a cash flow statement?